Optifarm
ActiveSummary
Optifarm has been active since 1970 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €413k and a net result of €72k. Equity is growing by ~7% per year across the filed fiscal years. Its solvency ranks better than 27% of 10359 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
57
/ 100
Fair
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability50▼-1
Solvency42▼-1
Growth78=
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €23k at 30 days acceptable
Liquidity tight (current ratio 1.07 against 0.88 in 2024; short-term debt: 28.1% and cash: 3.3% of total assets), and 83.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
16.8%
Return on assets
2.9%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-06-2026, 46 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
46 d early
2024
65 d early
2023
89 d early
2022
62 d early
2021
40 d early
2020
45 d early
2019
11 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Source amounts without an identifiable currency are assumed to be EUR.
Equity
€413k=
2024 · €413k
2018: €277k
2019: €277k
2020: €277k
2021: €314k
2022: €433k
2023: €413k
2024: €413k
2018 → 2025
Total assets
€2.46M▲ 6.9%
2024 · €2.30M
2018: €612k
2019: €569k
2020: €804k
2021: €674k
2022: €1.08M
2023: €1.31M
2024: €2.30M
2018 → 2025
Net result
€72k▲ 29.7%
2024 · €55k
2018: €28k
2019: €14k
2020: €17k
2021: €64k
2022: €198k
2023: €59k
2024: €55k
2018 → 2025
Working capital
€49k
2024 · €-69k
2018: €133k
2019: €139k
2020: €152k
2021: €225k
2022: €379k
2023: €129k
2024: €-69k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€314k-€433k▲ 37.9%€413k▼ 4.6%€413k=€413k=
Operating result€78k-€272k▲ 249%€106k▼ 61.2%€112k▲ 5.7%€173k▲ 55.5%
Net result€64k-€198k▲ 210%€59k▼ 70.4%€55k▼ 5.6%€72k▲ 29.7%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 55% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.46M
Fixed assets
€1.72M ▼ 4.1%
Current assets
€741k ▲ 45.5%
Equity and liabilities €2.46M
Equity
€413k =
Debt
€2.05M ▲ 8.4%
Debt's share of the balance-sheet total rises from 82.1% to 83.2%. Debt is higher.
Key figures and ratios
EBITDA
€281k▲
2024 · €202k
Cash flow
€179k▲
2024 · €146k
Current ratio
1.07▲
2024 · 0.88
Quick ratio
0.83▲
2024 · 0.60
Debt to equity
4.96▲
2024 · 4.57
ROE
17.4%▲
2024 · 13.4%
ROA
2.9%▲
2024 · 2.4%
Interest coverage
3.29▼
2024 · 3.52
Debt ≤ 1 year
€692k▲
2024 · €579k
Debt > 1 year
€1.36M▲
2024 · €1.31M
Income taxes
€21k
Staff costs
€301k▲
2024 · €176k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 52 lines
Balance sheet
Code20242025
Assets
Total assets20/58€2.30M€2.46M▲
Fixed assets21/28€1.79M€1.72M▼
Intangible fixed assets21€35k€32k▼
Tangible fixed assets22/27€1.74M€1.67M▼
Land and buildings22€1.18M€1.14M▼
Plant, machinery and equipment23€552k€526k▼
Furniture and vehicles24€10k€7k▼
Financial fixed assets28€19k€14k▼
Current assets29/58€509k€741k▲
Stocks and contracts in progress3€161k€167k▲
Stocks30/36€161k€167k▲
Amounts receivable within one year40/41€190k€213k▲
Trade receivables40€111k€162k▲
Other amounts receivable41€80k€50k▼
Current investments50/53-€273k
Cash at bank and in hand54/58€146k€81k▼
Deferred charges and accrued income490/1€12k€8k▼
Equity and liabilities
Total equity and liabilities10/49€2.30M€2.46M▲
Equity10/15€413k€413k=
Contributions10/11€39k€39k=
Reserves13€374k€374k=
Distributable reserves133€374k€374k=
Amounts payable17/49€1.89M€2.05M▲
Amounts payable after more than one year17€1.31M€1.36M▲
Financial debts170/4€1.31M€1.36M▲
Amounts payable within one year42/48€579k€692k▲
Current portion of amounts payable after more than one year42€137k€95k▼
Financial debts43€14k€54k▲
Credit institutions430/8€14k€54k▲
Trade debts44€329k€433k▲
Suppliers440/4€329k€433k▲
Taxes, remuneration and social security45€22k€18k▼
Taxes450/3-€7k
Remuneration and social security454/9€22k€11k▼
Other amounts payable47/48€77k€92k▲
Income statement
Code20242025
Remuneration, social security and pensions62€176k€301k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€90k€107k▲
Other operating charges640/8€21k€2k▼
Gross operating margin9900€399k€584k▲
Operating profit (loss)9901€112k€173k▲
Financial income75/76B€1k€5k▲
Recurring financial income75€1k€5k▲
Financial charges65/66B€57k€85k▲
Recurring financial charges65€57k€85k▲
Profit (loss) for the period before taxes9903€55k€93k▲
Income taxes67/77-€21k
Profit (loss) for the period9904€55k€72k▲
Profit (loss) for the period to be appropriated9905€55k€72k▲
Appropriation of the result
Profit (loss) to be appropriated9906€55k€72k▲
Profit to be distributed694/7€55k€72k▲
Return on contributions (dividend)694€55k€72k▲
Social balance
Average headcount (FTE)90872.22.4▲
The notes to these accounts (16 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
15-06
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
27-05
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
03-05
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
30-05
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Highest result since 2018net €198k ▲210%
Operating result €272k, net result €198k, both a record.
21-06
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
16-06
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
20-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-12
Financial
Weakest financial yearnet €14k ▼52%
Net result drops to €14k, the lowest in the series; recovery starts the following year.
26-06
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
14-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 14 days late
2017
30-05
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zottegem · 1 establishment unit since 1971
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Heldenlaan 169620 ZottegemGround area
513 m²
Building footprint
491 m²
Volume, LiDAR
3,016 m³
Parcel 41081A0083/00P000, Flanders · tallest building 14.3 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
Heldenlaan 16, 9620 Zottegem
since 19712.005.634.851
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 41081A0083/00P000 | Flanders | 513 m² | 1 · 491 m² | 14.3 m · 1 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).
Public money · subsidies and aid
Flemish government
2023 · 1 entry · 159 EUR awarded · 159 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2023 | 1 | 159 EUR | 159 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Recognitions · licences · registrations
Food safety, FASFC
1 siteZottegem2.005.634.851
Similar companies · same sector, comparable size
PHARMA 310505
BE 0643.802.856
Brugge · Eq €413,071
APOTHEEK DE BEER
BE 0826.294.401
Roeselare · Eq €413,146
APOTHEEK ONKERZELE
BE 0535.663.890
Geraardsbergen · Eq €413,478
APOTHEEK VAN DER MEULEN
BE 0460.250.746
Zele · Eq €413,899
CYNARA
BE 0862.412.845
Brussel · Eq €413,946
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,422 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded28-12-1970
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
47742Retail sale of prescription glasses, lenses and sunglasses
Sources
Crossroads Bank for EnterprisesNational Bank · 49 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.